Stroke Thrombectomy and Aneurysm Registry

Condition(s) studied

Investigational drug(s) / intervention(s)

Stroke/Thrombectomy/Aneurysm-specific surgical procedures: Participants are retrospectively and/or prospectively entered into registry based on disease indication and respective surgical procedure.

Study summary

This international multi-center registry is used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an artery, abnormal tangling of blood vessels, abnormal formation of blood vessels, tearing of vein, and bleeding in the brain. This information is used to help predict outcomes that undergo an operation for treatment of the above-listed brain injuries. Additionally, the information is used to compare techniques and devices' effects on technical and clinical outcomes.

Eligibility

Primary outcome measure(s)

• Post-procedure hemorrhage rate changes — 90 days
  Researchers examine changes in hemorrhage rates in post-stroke patients
• Occlusion rates — 90 days
  Measure of how thrombectomy procedure success in relation to reduced occlusion
• Complication rates — 90 days
  Measure of post-procedure complication rates in stroke/aneurysm patients
• Retreatment rates — 90 days
  Measure of patient retreatment post-procedure

Trial sites (63)

+ 23 more sites — see the full list on the official registry below.

Other trials for the same condition